Announced
Completed
Financials
Sources
Tags
Private Equity
Completed
Cross Border
Minority
Friendly
Single Bidder
Health Care Services
Medical Equipment
United States
radiotherapy
Acquisition
Private
Venture Capital
Synopsis
The Rise Fund, a venture capital firm, led the $105m investment in RefleXion, a radiotherapy provider, with participation from Ally Bridge, Pfizer Ventures, Johnson & Johnson, Venrock, Catalio and Hillenbrand. “Closing an equity round of this size strongly affirms the conviction of our new and existing investors in fueling innovation for breakthrough treatment options, like SCINTIX therapy, in the battle against cancer. TPG’s support has been foundational in our journey, and we are gratified that they are leading a significant investment in RefleXion," Todd Powell, RefleXion President and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.